| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.500 | 61.207 | 55.862 | 39.354 | 68.968 | 799.615 | 545.696 | 835.677 | 695.010 | 543.056 |
| Total Income - EUR | 64.500 | 61.230 | 55.945 | 39.354 | 71.662 | 802.554 | 545.739 | 841.108 | 714.196 | 548.967 |
| Total Expenses - EUR | 64.358 | 59.640 | 51.245 | 36.422 | 61.605 | 653.679 | 444.946 | 598.569 | 553.344 | 495.389 |
| Gross Profit/Loss - EUR | 142 | 1.590 | 4.700 | 2.932 | 10.057 | 148.875 | 100.793 | 242.539 | 160.852 | 53.578 |
| Net Profit/Loss - EUR | 119 | 202 | 3.024 | 2.268 | 9.367 | 141.346 | 96.934 | 236.831 | 154.804 | 47.934 |
| Employees | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
Check the financial reports for the company - Organon Biotec Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.536 | 3.328 | 3.017 | 3.138 | 3.915 | 2.370 | 806 | 41.188 | 42.605 | 56.016 |
| Current Assets | 10.667 | 21.103 | 24.563 | 15.116 | 31.038 | 219.884 | 204.072 | 215.682 | 412.788 | 284.168 |
| Inventories | 0 | 1.037 | 0 | 0 | 0 | 52.942 | 17.185 | 16.198 | 31.526 | 21.403 |
| Receivables | 5.317 | 14.636 | 11.346 | 7.462 | 7.886 | 117.291 | 117.736 | 161.188 | 214.013 | 172.478 |
| Cash | 5.350 | 5.430 | 13.217 | 7.655 | 23.152 | 49.651 | 69.151 | 38.296 | 167.249 | 90.287 |
| Shareholders Funds | 3.772 | 3.945 | 6.902 | 9.043 | 13.599 | 116.387 | 159.523 | 191.936 | 280.235 | 162.717 |
| Social Capital | 45 | 53 | 53 | 52 | 51 | 50 | 2.030 | 2.036 | 2.022 | 2.010 |
| Debts | 12.431 | 20.486 | 20.678 | 9.212 | 21.354 | 105.868 | 45.356 | 64.934 | 175.158 | 181.280 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Organon Biotec Srl